Lexicon Pharmaceuticals
LXRX
#7142
Rank
โ‚ฌ0.43 B
Marketcap
1,20ย โ‚ฌ
Share price
-1.41%
Change (1 day)
78.94%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ49.94 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is โ‚ฌ49.94 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ0.10 B8.57%
2023-12-31โ‚ฌ95.94 M86.13%
2022-12-31โ‚ฌ51.54 M2461.56%
2021-12-31โ‚ฌ2.01 M-80.68%
2020-12-31โ‚ฌ10.41 M-95.25%
2019-12-31โ‚ฌ0.21 B2.43%
2018-12-31โ‚ฌ0.21 B4.6%
2017-12-31โ‚ฌ0.20 B112.29%
2016-12-31โ‚ฌ96.44 M2.45%
2015-12-31โ‚ฌ94.14 M6.34%
2014-12-31โ‚ฌ88.52 M458.84%
2013-12-31โ‚ฌ15.84 M-10.65%
2012-12-31โ‚ฌ17.72 M-7.51%
2011-12-31โ‚ฌ19.16 M-10.48%
2010-12-31โ‚ฌ21.41 M-54.18%
2009-12-31โ‚ฌ46.73 M114.29%
2008-12-31โ‚ฌ21.81 M1.51%
2007-12-31โ‚ฌ21.48 M-11.92%
2006-12-31โ‚ฌ24.39 M-21.77%
2005-12-31โ‚ฌ31.18 M12.41%
2004-12-31โ‚ฌ27.74 M-38.01%
2003-12-31โ‚ฌ44.75 M1069.56%
2002-12-31โ‚ฌ3.82 M
2000-12-31โ‚ฌ3.02 M-36.38%
1999-12-31โ‚ฌ4.74 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ0.47 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ2.32 B 4,552.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚ฌ29.05 M-41.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.51 B 939.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ30.64 B 61,258.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.26 B 427.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ2.21 B 4,329.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.38 B 675.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.28 B 479.51%๐Ÿ‡บ๐Ÿ‡ธ USA